See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
No Insider Transactions found for Biomea Fusion, Inc.
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Dec 02, 2025 Hitchcock Michael J.M. |
Hitchcock Michael J.M.
Interim CEO
|
Buy |
100,000 | $0.99 | 100,000 $0.99 $99,180 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Sep 30, 2024 Hitchcock Michael J.M. |
Hitchcock Michael J.M.
|
Buy |
10,000 | $10.06 | 10,000 $10.06 $100,600 |
Jun 11, 2024 Valle Franco |
Valle Franco
CFO
|
Buy |
12,509 | $4.43 | 12,509 $4.43 $55,361 |
Jun 01, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
50,000 | $34.56 | 50,000 $34.56 $1,728,165 |
May 31, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
75,000 | $33.81 | 75,000 $33.81 $2,535,750 |
May 12, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
25,000 | $33.84 | 25,000 $33.84 $846,000 |
May 09, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
150,000 | $34.50 | 150,000 $34.50 $5,175,720 |
May 08, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
100,000 | $33.99 | 100,000 $33.99 $3,399,310 |
Apr 20, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
200,000 | $29.12 | 200,000 $29.12 $5,823,760 |
Mar 31, 2023 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
200,000 | $31.25 | 200,000 $31.25 $6,250,000 |
Mar 30, 2023 Chen Bihua |
Chen Bihua
|
Buy |
400,000 | $30.00 | 400,000 $30.00 $12,000,000 |
Nov 14, 2022 Hitchcock Michael J.M. |
Hitchcock Michael J.M.
|
Buy |
5,000 | $7.93 | 5,000 $7.93 $39,650 |
Nov 11, 2022 Valle Franco |
Valle Franco
CFO
|
Buy |
4,100 | $7.63 | 4,100 $7.63 $31,286 |
Aug 16, 2022 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Buy |
30,684 | $13.87 | 30,684 $13.87 $425,648 |
Jul 21, 2022 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
34,658 | $11.21 | 34,658 $11.21 $388,516 |
Jun 24, 2022 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Sell |
34,658 | $11.76 | 34,658 $11.76 $407,578 |
Jan 14, 2022 Valle Franco |
Valle Franco
CFO
|
Buy |
10,000 | $8.68 | 10,000 $8.68 $86,767 |
Sep 17, 2021 Stergiopoulos Sotirios |
Stergiopoulos Sotirios
|
Buy |
34,658 | $10.96 | 34,658 $10.96 $379,852 |
Sep 17, 2021 A2A Pharmaceuticals, Inc. |
A2A Pharmaceuticals, Inc.
|
Buy |
34,658 | $10.96 | 34,658 $10.96 $379,852 |
Aug 23, 2021 Butler Thomas Andrew |
Butler Thomas Andrew
CEO
|
Buy |
24,000 | $13.20 | 24,000 $13.20 $316,872 |
Aug 23, 2021 Erdtmann Rainer M |
Erdtmann Rainer M
President & COO
|
Buy |
24,000 | $13.20 | 24,000 $13.20 $316,872 |
TOP
